Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques

Biochemical and Biophysical Research Communications

Volumn 401, Issue 4, 2010, Pages 574-580

  Olson, Fredrik J ^a   Sihlbom, Carina ^b   Davidsson, Pia ^b   Hulthe, Johannes ^b   Fagerberg, Björn ^a   Bergström, Göran ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Arteriosclerosis; Biomarker; Human; Plaque vulnerability; Proteomics

Indexed keywords

ACTIN; APOLIPOPROTEIN E; FERRITIN; FIBRINOGEN; LACTATE DEHYDROGENASE; PROTEIN S 100; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 77958449752     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.103     Document Type: Article

References (29)

1. Redgrave J.N., Lovett J.K., Gallagher P.J., Rothwell P.M. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006, 113:2320-2328.
2. Carr S., Farb A., Pearce W.H., et al. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J. Vasc. Surg. 1996, 23:755-765.
3. Helderman F., Segers D., De Crom R., et al. Effect of shear stress on vascular inflammation and plaque development. Curr. Opin. Lipidol. 2007, 18:527-533.
4. Fagerberg B., Ryndel M., Kjelldahl J., et al. Differences in lesion severity and cellular composition between in vivo assessed upstream and downstream sides of human symptomatic carotid atherosclerotic plaques. J. Vasc. Res. 2010, 47:221-230.
5. Dirksen M.T., Van der Wal A.C., van den Berg F.M. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation 1998, 98:2000-2003.
6. Yilmaz A., Lipfert B., Cicha I., et al. Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques. Exp. Mol. Pathol. 2007, 82:245-255.
7. Svensson P.A., Olson F.J., Hagg D.A., et al. Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis. Int. J. Mol. Med. 2008, 22:459-464.
8. Binder B.R., Mihaly J., Prager G.W. UPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb. Haemost. 2007, 97:336-342.
9. Donners M.M., Verluyten M.J., Bouwman F.G., et al. Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J. Pathol. 2005, 206:39-45.
10. Lepedda A.J., Cigliano A., Cherchi G.M., et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009, 203:112-118.
11. Sung H.J., Ryang Y.S., Jang S.W., et al. Proteomic analysis of differential protein expression in atherosclerosis. Biomarkers 2006, 11:279-290.
12. Park H.K., Park E.C., Bae S.W., et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114:886-893.
13. Sihlbom C., Kanmert I., Bahr H., Davidsson P. Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins. J. Proteome Res. 2008, 7:4191-4198.
14. Ishihama Y., Oda Y., Tabata T., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 2005, 4:1265-1272.
15. Bagnato C., Thumar J., Mayya V., et al. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2007, 6:1088-1102.
16. You S.A., Wang Q. Ferritin in atherosclerosis. Clin. Chim. Acta 2005, 357:1-16.
17. Cojocaru I.M., Cojocaru M., Musuroi C., et al. Study of some markers of inflammation in atherothrombotic pathogenesis of acute ischemic stroke. Rom. J. Intern. Med. 2002, 40:103-116.
18. Green D., Foiles N., Chan C., et al. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA study. Atherosclerosis 2009, 202:623-631.
19. Johansson F., Kramer F., Barnhart S., et al. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. Proc. Natl. Acad. Sci. USA 2008, 105:2082-2087.
20. Miyamoto S., Ueda M., Ikemoto M., et al. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina. Heart 2008, 94:1002-1007.
21. Buono R.J., Lang R.K. Hypoxic repression of lactate dehydrogenase-B in retina. Exp. Eye Res. 1999, 69:685-693.
22. Hulten L.M., Olson F.J., Aberg H., et al. 15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha. Eur. J. Clin. Invest. 2010, 40:11-17.
23. Cederholm A., Frostegard J. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann. NY Acad. Sci. 2007, 1108:96-103.
24. Martinet W., Schrijvers D.M., De Meyer G.R., et al. Western array analysis of human atherosclerotic plaques: downregulation of apoptosis-linked gene 2. Cardiovasc. Res. 2003, 60:259-267.
25. Kwon M., MacLeod T.J., Zhang Y., Waisman D.M. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci. 2005, 10:300-325.
26. Henkin J., Marcotte P., Yang H.C. The plasminogen-plasmin system. Prog. Cardiovasc. Dis. 1991, 34:135-164.
27. Sharma M.C., Sharma M. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr. Pharm. Des. 2007, 13:3568-3575.
28. O'Connell P.A., Surette A.P., Liwski R.S., et al. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 2010, 116:1136-1146.
29. Peeters W., Hellings W.E., De Kleijn D.P., et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 2009, 29:128-133.